ESHRE guideline: management of women with endometriosis.

By G. Dunselman, N. Vermeulen, C. Becker, C. Calhaz-Jorge, T. D'Hooghe, B. Bie, O. Heikinheimo, A. Horne, L. Kiesel, A. Nap and 4 more. Human Reproduction, 2014

1,979 citations recorded by the source corpus.

Subfields: Obstetrics and Gynecology, Public Health, Environmental and Occupational Health, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/ab9b257c75eec81d944e330dc5ce0162c50f436e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Janse
2. B. Cartwright
3. D. Braat
4. E. Hogervorst
5. C. Zillikens
6. M. Davies
7. J. Bartlett
8. R. Anderson

Citations in the corpus

• ESHRE Guideline: management of women with premature ovarian insufficiency. (2016, background): “…combined estrogen/progestogen therapy can be effective for the treatment of vasomotor symptoms and may reduce the risk of disease reactivation (Dunselman et al., 2014) C Women with POI and migraine Migraine should not be seen as a contraindication to HRT use by women with POI…”
• ESHRE guideline: endometriosis (2022, neutral): “The current guideline and recommendations are an update of the ESHRE endometriosis guidelines published in 2013 and 2005 (Kennedy et al. , 2005; Dunselman et al. , 2014).”